Previous Close | 0.1750 |
Open | 0.1750 |
Bid | 0.1700 x 0 |
Ask | 0.1800 x 0 |
Day's Range | 0.1750 - 0.1800 |
52 Week Range | 0.1100 - 0.4000 |
Volume | 145,010 |
Avg. Volume | 223,311 |
Market Cap | 28.465M |
Beta (5Y Monthly) | 1.57 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0070 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.40 |
VANCOUVER, BC, March 4, 2021 /CNW/ - ATAC Resources Ltd. (TSXV: ATC) ("ATAC") is pleased to announce its plans for the upcoming 2021 exploration season, and extension and re-pricing of certain warrants.
16, 2021 /CNW/ - ATAC Resources Ltd. (TSXV: ATC) ("ATAC") is pleased to provide an update on exploration activities at its road-accessible East Goldfield Property (the "Property"), located in the Goldfield Mining District of Nevada.
Three biotechs—Sana Biotechnology, Landos Biopharma, and Sensei Biotherapeutics—and chemicals specialist Atotech made their public-market debut Thursday. Here's how they fared.